Emeis's progress this Thursday follows the release of its mid-year 2025 results on September 30. The group reported a revenue of 2.91 billion euros for the first half, up 6.2% organically, driven particularly by favorable dynamics in nursing homes and international activities. The net loss was nearly halved to 137 million euros, from 257 million a year earlier, while free cash flow turned positive at 26 million euros for the first time in at least a decade. The group also confirmed its targets for the full year 2025, reassuring investors about the recovery trajectory that has been underway for several quarters.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
The stock closed Thursday's session at 15.51 euros, up 6.45% from the previous day. This increase is part of a sustained upward trend, with a gain of 4.52% over the last seven days and 35.1% over the past three months. Trading volumes remained moderate, representing 0.33% of the capital, in a Parisian market trending downward where the CAC 40 declined by 0.23%. Over one year, the performance now reaches 170.5%, significantly outperforming the reference index, which has increased by 6.91% over the same period.
From a chart perspective, breaking the resistance threshold at 14.97 euros marks a significant technical event, with the price now moving above this key level. The relative strength index stands at 73, indicating a bullish acceleration phase but also signaling an overbought zone where a technical pause becomes statistically more likely. Moreover, the stock remains well above its 50-day moving average at 13.03 euros, and 200-day moving average at 10.71 euros, confirming the strength of the underlying trend observed since the beginning of the year.
SectorSanté · Etablissements de santé / EHPAD›Etablissements de santé
Context
Period
Period: 9M 2025
Guidance from the release
Croissance organique soutenue (+6,4% à fin septembre 2025, +7,0% au T3), amélioration notable des taux d'occupation, objectifs de cessions dépassés (2,1 Md€) et confirmation des perspectives 2025 et de la trajectoire 2024-2028.
Risks mentioned
Risques et incertitudes liés aux conditions de marché futures pouvant affecter les résultats prévisionnels
Risque de non-réalisation ou de délai des cessions actuellement sécurisées ou en négociation
Impact transitoire des ouvertures récentes sur les taux d'occupation dans certaines zones
Opportunities identified
Croissance démographique des plus de 75 ans (+30% d'ici 10 ans) créant une demande structurelle accrue
Déficit structurel d'offre (déficit attendu de lits sur principaux marchés) offrant une forte visibilité commerciale
Possibilités de capture d'effets prix favorables et d'amélioration de marges opérationnelles
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.